Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice

scientific article published on May 1, 1977

Efficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.16.2.717-719.1977
P953full work available at URLhttp://iai.asm.org/cgi/content/abstract/16/2/717
https://europepmc.org/articles/PMC421016
https://europepmc.org/articles/PMC421016?pdf=render
https://journals.asm.org/doi/pdf/10.1128/iai.16.2.717-719.1977
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/193798/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/193798/pdf/?tool=EBI
P932PMC publication ID421016
P698PubMed publication ID193798

P2093author name stringR. R. McKendall
P2860cites workTHE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. II. A CELLULAR BASIS FOR THE DEVELOPMENT OF RESISTANCE WITH AGEQ27483850
Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infectionQ34123889
Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infectionQ34483710
The Axis-Cylinders of Peripheral Nerves as Portals of Entry to the Central Nervous System for the Virus of Herpes Simplex in Experimentally Infected RabbitsQ35911181
Comparative studies of type 1 and type 2 & 'herpes simplex' virusesQ36168023
The incidence of Herpesvirus hominis antibody in the populationQ36251747
THE PATHOGENESIS OF HERPES VIRUS ENCEPHALITIS. I. VIRUS PATHWAYS TO THE NERVOUS SYSTEM OF SUCKLING MICE DEMONSTRATED BY FLUORESCENT ANTIBODY STAININGQ36266931
Type 1 and type 2 herpes simplex viruses: serological and biological differencesQ37138565
A review of the identification and titration of antibodies to herpes simplex viruses type 1 and type 2 in human seraQ39898376
Infection with herpes-simplex viruses 1 and 2. II.Q39898602
Infection with herpes-simplex viruses 1 and 2. 3.Q39898637
Invasion of the Central Nervous System by Herpes Simplex Virus Type 1 after Subcutaneous Inoculation of Immunosuppressed MiceQ39916870
Latent Infection of Sensory Ganglia with Herpes Simplex Virus: Efficacy of ImmunizationQ39934802
Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infectionQ39968639
Depression of acquired resistance against herpes simplex virus infection in neonatally thymectomized miceQ45811007
Herpes virus latency in spinal ganglia of mice without illness.Q45818056
Effect of antithymocyte serum on herpesvirus hominis (type 1) infection in adult mice.Q54312877
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmicrobiologyQ7193
immunologyQ101929
Herpes simplex virus type 1Q655331
immunizationQ1415366
P304page(s)717-719
P577publication date1977-05-01
P1433published inInfection and ImmunityQ6029193
P1476titleEfficacy of herpes simplex virus type 1 immunization in protecting against acute and latent infection by herpes simplex virus type 2 in mice
P478volume16

Reverse relations

cites work (P2860)
Q36669790B and T cell epitopes of glycoprotein D of herpes simplex virus type 1
Q40183508Colonization of murine ganglia by a superinfecting strain of herpes simplex virus
Q33641432Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine
Q46573161Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine
Q45860284Glycoprotein gB of herpes simplex virus expresses type-common and type-specific antigenic determinants in vivo
Q41532313Herpes simplex virus types 1 and 2 and multiple sclerosis
Q40616009Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections
Q59358859Immunization by Replication-Competent Controlled Herpesvirus Vectors
Q36089649Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection
Q36917531Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity
Q36438105Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains
Q28323036Latent Herpes Simplex Virus Infections in Sensory Ganglia of Hairless Mice Prevented by Acycloguanosine
Q40156772Latent herpes simplex virus in ganglia of mice after primary infection and reinoculation at a distant site
Q33659149Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis
Q45803445Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus
Q40081296Prevention of herpes simplex virus diseases in man
Q40161394Protective effect of an oral infection with Herpes simplex virus type 1 against subsequent genital infection with Herpes simplex virus type 2
Q45801486The influence of different modes of immunization on the experimental genital herpes simplex virus infection of mice
Q45002369The preparation, efficacy and safety of ‘antigenoid’ vaccine NFU1 (S−L+) MRC toward prevention ofHerpes simplex virus infections in human subjects

Search more.